| Increasing the specificity of diagnostic criteria for schwannomatosis. | |
| | |
MedLine Citation:
|
PMID: 16534111 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Diagnostic criteria for schwannomatosis have been proposed in a recent consensus statement. These criteria permit schwannomatosis to be distinguished from neurofibromatosis type 2 (NF2) in most patients, but there is some clinical overlap between the two diseases. In this study, the authors use data from the population-based United Kingdom NF2 Registry to recommend modifications that increase the specificity of the schwannomatosis diagnostic criteria. |
| | |
Authors:
|
Michael E Baser; J M Friedman; D Gareth R Evans |
Publication Detail:
|
Type: Case Reports; Comparative Study; Journal Article |
Journal Detail:
|
Title: Neurology Volume: 66 ISSN: 1526-632X ISO Abbreviation: Neurology Publication Date: 2006 Mar |
Date Detail:
|
Created Date: 2006-03-14 Completed Date: 2006-04-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0401060 Medline TA: Neurology Country: United States |
Other Details:
|
Languages: eng Pagination: 730-2 Citation Subset: AIM; IM |
Affiliation:
|
michael.baser@verizon.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Age of Onset Child, Preschool Diagnosis, Differential Female Humans Male Neurilemmoma / diagnosis* Neurofibromatosis 2 / diagnosis* Sensitivity and Specificity |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Figuring out drawing-induced epilepsy.
Next Document: Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers.